217 related articles for article (PubMed ID: 8709939)
1. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
Saji S; Toi M; Tominaga T
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.
Toi M; Inada K; Suzuki H; Tominaga T
Breast Cancer Res Treat; 1995; 36(2):193-204. PubMed ID: 8534867
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.
Horak ER; Leek R; Klenk N; LeJeune S; Smith K; Stuart N; Greenall M; Stepniewska K; Harris AL
Lancet; 1992 Nov; 340(8828):1120-4. PubMed ID: 1279332
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer.
Zhou D; Cheng SQ; Ji HF; Wang JS; Xu HT; Zhang GQ; Pang D
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1719-27. PubMed ID: 20229034
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic value of angiogenic activity evaluation with contrast enhanced power doppler imaging in axillary-node-negative breast carcinoma].
Li YJ; Zhang XL; Wen G
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):877-80. PubMed ID: 17953829
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.
Toi M; Kashitani J; Tominaga T
Int J Cancer; 1993 Sep; 55(3):371-4. PubMed ID: 7690738
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.
Ludovini V; Sidoni A; Pistola L; Bellezza G; De Angelis V; Gori S; Mosconi AM; Bisagni G; Cherubini R; Bian AR; Rodinò C; Sabbatini R; Mazzocchi B; Bucciarelli E; Tonato M; Colozza M
Breast Cancer Res Treat; 2003 Sep; 81(2):159-68. PubMed ID: 14572158
[TBL] [Abstract][Full Text] [Related]
12. [Tumor angiogenesis in node-negative breast carcinoma].
Li HJ; Jing J; Zhao YB; Zhu JQ; Zhang SY; Shi ZD
Ai Zheng; 2002 Jan; 21(1):75-8. PubMed ID: 12500403
[TBL] [Abstract][Full Text] [Related]
13. [The correlation between tumor angiogenesis and lymph node metastasis in primary breast carcinoma].
Jiang X; Huang X; Li J
Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):583-5. PubMed ID: 10678042
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of microvessel density in breast cancer of Thai women.
Kanjanapanjapol S; Wongwaisayawan S; Phuwapraisirisan S; Wilasrusmee C
J Med Assoc Thai; 2007 Feb; 90(2):282-90. PubMed ID: 17375633
[TBL] [Abstract][Full Text] [Related]
17. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
Shrivastav S; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
[TBL] [Abstract][Full Text] [Related]
18. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer.
de Jong JS; van Diest PJ; Baak JP
Histopathology; 2000 Apr; 36(4):306-12. PubMed ID: 10759944
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer.
Boxer GM; Tsiompanou E; Levine T; Watson R; Begent RH
Tumour Biol; 2005; 26(1):1-8. PubMed ID: 15741766
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
